BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38570251)

  • 1. Usefulness of mid-regional proadrenomedullin levels in the resuscitation phase of severely burned patients and its utility in early sepsis detection.
    Flores E; Estébanez B; Quintana M; Fernández-Puntero B; Nanwani K; Cachafeiro L; Martínez JR; Agrifoglio A; Sánchez-Sánchez M
    Burns; 2024 Aug; 50(6):1519-1527. PubMed ID: 38570251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR-proADM: A New Biomarker for Early Diagnosis of Sepsis in Burned Patients.
    Gille J; Ostermann H; Dragu A; Sablotzki A
    J Burn Care Res; 2017; 38(5):290-298. PubMed ID: 28221298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.
    Bernal-Morell E; García-Villalba E; Vera MDC; Medina B; Martinez M; Callejo V; Valero S; Cinesi C; Piñera P; Alcaraz A; Marin I; Muñoz A; Cano A
    J Infect; 2018 Mar; 76(3):249-257. PubMed ID: 29246637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR- proADM to detect specific types of organ failure in infection.
    Andrés C; Andaluz-Ojeda D; Cicuendez R; Nogales L; Martín S; Martin-Fernandez M; Almansa R; Calvo D; Esteban-Velasco MC; Vaquero-Roncero LM; Ríos-Llorente A; Sanchez-Barrado E; Muñoz-Bellvís L; Aldecoa C; Bermejo-Martin JF
    Eur J Clin Invest; 2020 Jun; 50(6):e13246. PubMed ID: 32307701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
    Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F;
    Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of procalcitonin and mid-regional pro-adrenomedullin in septic paediatric patients.
    Solé-Ribalta A; Bobillo-Pérez S; Valls A; Girona-Alarcón M; Launes C; Cambra FJ; Jordan I; Esteban E
    Eur J Pediatr; 2020 Jul; 179(7):1089-1096. PubMed ID: 31974673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.
    Christ-Crain M; Morgenthaler NG; Struck J; Harbarth S; Bergmann A; Müller B
    Crit Care; 2005; 9(6):R816-24. PubMed ID: 16356231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.
    Elke G; Bloos F; Wilson DC; Brunkhorst FM; Briegel J; Reinhart K; Loeffler M; Kluge S; Nierhaus A; Jaschinski U; Moerer O; Weyland A; Meybohm P;
    Crit Care; 2018 Mar; 22(1):79. PubMed ID: 29562917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin and MR-Proadrenomedullin Combination with SOFA and qSOFA Scores for Sepsis Diagnosis and Prognosis: A Diagnostic Algorithm.
    Spoto S; Cella E; de Cesaris M; Locorriere L; Mazzaroppi S; Nobile E; Lanotte AM; Pedicino L; Fogolari M; Costantino S; Dicuonzo G; Ciccozzi M; Angeletti S
    Shock; 2018 Jul; 50(1):44-52. PubMed ID: 29023361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of mid-regional proadrenomedullin in ARDS COVID-19 patients: the experience of a single, Italian Center.
    Benedetti I; Spinelli D; Callegari T; Bonometti R; Molinaro E; Novara E; Cassinari M; Frino C; Guaschino R; Boverio R; Lauritano EC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1743-1751. PubMed ID: 33629344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
    Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
    Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of mid-regional pro-adrenomedullin in sepsis are associated with risk of death.
    Valenzuela-Sánchez F; Valenzuela-Méndez B; Bohollo de Austria R; Rodríguez-Gutiérrez JF; Estella-García Á; Fernández-Ruiz L; González-García MÁ; Rello J
    Minerva Anestesiol; 2019 Apr; 85(4):366-375. PubMed ID: 30207133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mr-Proadm Elevation Upon Icu Admission Predicts the Outcome of Septic Patients and is Correlated with Upcoming Fluid Overload.
    Charles PE; Péju E; Dantec A; Bruyère R; Meunier-Beillard N; Dargent A; Prin S; Wilson D; Quenot JP
    Shock; 2017 Oct; 48(4):418-426. PubMed ID: 28414691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study.
    Viaggi B; Poole D; Tujjar O; Marchiani S; Ognibene A; Finazzi S
    PLoS One; 2018; 13(8):e0201491. PubMed ID: 30102716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections.
    Angeletti S; Spoto S; Fogolari M; Cortigiani M; Fioravanti M; De Florio L; Curcio B; Cavalieri D; Costantino S; Dicuonzo G
    APMIS; 2015 Sep; 123(9):740-8. PubMed ID: 26058482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study.
    Saeed K; Wilson DC; Bloos F; Schuetz P; van der Does Y; Melander O; Hausfater P; Legramante JM; Claessens YE; Amin D; Rosenqvist M; White G; Mueller B; Limper M; Callejo CC; Brandi A; Macchi MA; Cortes N; Kutz A; Patka P; Yañez MC; Bernardini S; Beau N; Dryden M; van Gorp ECM; Minieri M; Chan L; Rood PPM; Del Castillo JG
    Crit Care; 2019 Feb; 23(1):40. PubMed ID: 30736862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin, MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test Combination.
    Angeletti S; Dicuonzo G; Fioravanti M; De Cesaris M; Fogolari M; Lo Presti A; Ciccozzi M; De Florio L
    Dis Markers; 2015; 2015():951532. PubMed ID: 26635427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity.
    Andaluz-Ojeda D; Nguyen HB; Meunier-Beillard N; Cicuéndez R; Quenot JP; Calvo D; Dargent A; Zarca E; Andrés C; Nogales L; Eiros JM; Tamayo E; Gandía F; Bermejo-Martín JF; Charles PE
    Ann Intensive Care; 2017 Dec; 7(1):15. PubMed ID: 28185230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score.
    Travaglino F; De Berardinis B; Magrini L; Bongiovanni C; Candelli M; Silveri NG; Legramante J; Galante A; Salerno G; Cardelli P; Di Somma S
    BMC Infect Dis; 2012 Aug; 12():184. PubMed ID: 22874067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
    Morgenthaler NG; Struck J; Alonso C; Bergmann A
    Clin Chem; 2005 Oct; 51(10):1823-9. PubMed ID: 16099941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.